"Designing Growth Strategies is in our DNA"

UK Medical Devices Market Size, Share & Industry Analysis, By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Wound Management, Diabetes Care, Ophthalmic, Dental, Nephrology, General Surgery, and Others), By End-User (Hospitals & ASCs, Clinics, and Others), and Country Forecast, 2025-2032

Last Updated: December 08, 2025 | Format: PDF | Report ID: FBI114021

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The UK medical devices market size was valued at USD 18.17 billion in 2024. The market is projected to grow from USD 19.07 billion in 2025 to USD 27.90 billion by 2032, exhibiting a CAGR of 5.6% during the forecast period.

Medical devices include apparatus, instruments, machines, and implants, specifically designed and developed for medical purposes. These devices serve essential functions within healthcare, including diagnosis, prevention, monitoring, and treatment. They can also be used to investigate, modify, replace, or support anatomical structures or physiological processes, as well as for contraception. Substantially growing prevalence of chronic conditions, rapid technological advancements, and rising emphasis on superior patient care are prominent factors impacting the market’s growth.

The market observes extensive investments by key players such as Medtronic, Boston Scientific Corporation, and Abbott in the U.K. for product development, incorporation of new technologies, and healthcare expenditure. Furthermore, government initiatives such as the Accelerated Access Collaborative (AAC) and the NHS Innovation Accelerator promote the development and adoption of new medical technologies, particularly in diagnostics and digital solutions.

MARKET DYNAMICS

Market Drivers

Customer Preference for Advanced Devices Positively Impact Market Growth

The U.K. is witnessing a growing number of patients with long-term or chronic conditions. These patients are highly inclined toward supporting home-based care, self-monitoring, and minimal clinical intervention. Moreover, increasing accessibility, awareness, and superior clinical outcomes offered by advanced medical technologies are offering a favorable environment for the adoption of medical devices in the U.K.

The NHS’s gradual adoption of digital health solutions, including wearable monitors and connected drug delivery systems, is creating a demand among patients for tech-enabled interventions. People are getting comfortable with smartphone integrated devices or devices providing real-time data, particularly in diabetes, respiratory care, and cardiovascular monitoring.

  • In November 2024, NHS announced its plan to integrate the NHS app into Epic EPR for better patient care. The integration is intended to improvise patient engagement along with better accessibility to patient records.

Elderly patients and caregivers often seek devices that are user-friendly, reduce hospital visits, and improve adherence. There is also a rising trust in AI-enabled diagnostic tools, as long as they are NHS-approved or CE-marked. 

Market Restraints

Challenges Associated with Regulatory Bodies and Product Approvals Discourage Growth

Stringent medical device regulations in the U.K. is one of the critical restraints affecting the UK medical devices market growth, along with the complexities introduced by regulatory separation from the EU. Post Brexit, the U.K. implemented its own regulatory framework, including mandates and prerequisites for UKCA (UK Conformity Assessed) marking for devices introduced in Great Britain, replacing the CE mark. This major change generated the need for separate approvals, dual documentation, and assessment of medical devices in the UK and EU, leading to longer timelines and higher costs for market access.

Furthermore, the U.K.'s regulations, while focusing on high safety standards, are demanding regarding post-market surveillance and evidence generation. This includes stricter clinical evaluation requirements, where manufacturers need to provide more robust data to support claims of safety and performance. The U.K. is witnessing limited approval bodies responsible for conformity assessments, which further increases delays in obtaining certification and hinders innovation, potentially prompting manufacturers to prioritize other markets for faster approvals and market access. Such unclear regulatory landscape and substantial administrative burden deter market growth.

Market Opportunities

Aging Population and Rising Adoption of Digital Health Technologies Propels Expansion

Aging population along with increasing prevalence of chronic conditions amongst this population offers substantial growth opportunities in the U.K. This growing prevalence of chronic illness gives rise to accelerated demand for diagnostics and therapeutic medical devices.

  • According to a data published by the British Diabetic Association in 2025, an estimated 5.8 million people in the U.K. are suffering from diabetes.

This growing demand gives companies a chance to develop and introduce technologically advanced medical devices. In addition, the U.K. is witnessing rising use of digital health technologies such as AI-based diagnostics, remote patient monitoring, and telehealth solutions. These technologies not only improve patient care but also reduce the burden on healthcare facilities.

  • In July 2022, Wolters Kluwer announced the launch of telemedicine resources in order to provide superior patient-centered virtual care. The new platform is developed in collaboration with George Washington University, intended to provide improved telehealth services.

Market Challenges

Data Privacy and Security Concerns Discourage Adoption of Certain Medical Devices

Rising cyber security threats and patient data safety problems offers a significant challenge for the growing UK medical devices market share. Currently, a lot of new medical devices are smart and connected. Devices such as wearable heart monitors, insulin pumps, or devices that check blood pressure at home can send information directly to doctors via apps or the internet. This internet connectivity is prone for hacking and data theft.

  • In August 2024, U.K.’s healthcare system witnessed a series of cyber-attacks leading to theft of sensitive patient information. Moreover, in June 2024, a London-based clinic was targeted by hackers which led to cancellation of 1,000 outpatient appointments and operations.

Hacking of medical devices enables altering device settings, transfer of data, and wrong monitoring output. Moreover, small companies or startups focus more on device function and less on protecting it from cyber threats. In the U.K., devices do not have to comply with strict regulations to meet cyber safety standards. Such weak protection against hackers and cybersecurity leads to lowering trust of patients and healthcare providers into connected devices.

UK MEDICAL DEVICES MARKET TRENDS

Increasing Adoption of Digital Technologies Emerges as a Prominent Trend in the U.K.

Growing utilization of digital and smart medical equipment is one of the important trends observed in the UK medical devices market. Several medical devices are designed to connect with mobile apps, computers, and cloud platforms so that patients and doctors can monitor health remotely. This trend is gaining popularity among people. It is a fast and convenient solution to manage their health without needing to visit a hospital every time.

  • In March 2025, researchers in UK published a study stating that a home-based physical activity program with a connected smartwatch helps newly diagnosed type-2 diabetes patients to manage the disease better.

The U.K. government and the NHS are also supporting this trend by promoting the use of digital health tools in public hospitals and health centers. They are encouraging companies to increase the manufacturing of connected devices so that healthcare becomes more accessible, especially in rural or remote areas. With people becoming more aware of their health and wanting more control over it, this shift toward digital medical devices is expected to keep growing.

Download Free sample to learn more about this report.

 

SEGMENTATION ANALYSIS

By Type

Increasing Number of Surgical Procedures Boost IVD’s Growth in the U.K.

Based on type, the market is segmented into orthopedic devices, cardiovascular devices, diagnostic imaging, IVD, MIS, wound management, diabetes care, ophthalmic, dental, nephrology, general surgery, and others.

The IVD segment dominated the UK medical devices market share in 2024 with growing number of surgical procedures coupled with rising incidence of chronic conditions. In addition, major market share of this segment is also attributed to availability of IVDs in almost all healthcare facilities.

The dental devices segment is projected to register the fastest CAGR during the forecast period. Certain factors such as growing demand for dental procedures, growing prevalence of dental conditions, and increasing number of dental products are accelerating market growth.

  • According to data published by the UK Oral Health Foundation in 2022, an estimated 31% of the population in the UK suffers from dental decay.

To know how our report can help streamline your business, Speak to Analyst

By End-User

Adoption of Advanced Medical Devices Spur Hospitals & ASCs Segment Growth

By end-user, the market is segregated into hospitals & ASCs, clinics, and others.

The hospitals and ASCs segment dominated the market in 2024. The rising adoption of advanced medical devices in hospitals & ASCs, improvement in healthcare infrastructure, and investments by medical device manufacturers for new product introductions boost segment growth.

The clinics segment is anticipated to exhibit fastest growth due to better accessibility, technological advancements, and focus on overall cost reduction. The UK medical devices market is witnessing a gradual shift of preference for visiting local clinics for regular checkups, small treatments, and follow-ups. Clinics are opening in more places and offering a wide range of services. This is attracting people seeking quick and short visits over spending long time in big hospitals.

COMPETITIVE LANDSCAPE

Key Market Players

Leading Companies Hold a Robust Share with Strong Portfolio and Introduction of New-Age Devices

The UK medical devices market is fragmented as the region observes a notable number of companies operating.

Medtronic, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Abbott, and Danaher Corporation are operating with a wide range of product portfolios. In addition, the market observes a growing investment by these companies for new product launches with strong focus on R&D to strengthen their product portfolio and the UK medical devices market shares.

There are several new entrants in the industry trying to establish their brands with devices and products with advanced technology. The increasing focus of these companies on developing and introducing novel products is a crucial factor contributing to their market shares.

LIST OF KEY MEDICAL DEVICES COMPANIES IN UK

KEY INDUSTRY DEVELOPMENTS

  • June 2025: Cambridge Healthcare Innovations announced development of Quattrii, the first dry powder inhaler (DPI) manufacturing engine which is capable of delivering large drug volumes in a single inhalation. The company is planning to make it available to pharmaceutical companies in Q4, 2025.
  • March 2025: Align Technology, Inc. announced the launch of new software called Align X-ray Insights, which is capable of analyzing 2D radiographs with the help of artificial intelligence.
  • March 2025: The collaboration of Mica and Milie announced the introduction of the first AI-based conversational wearable health band. The device has capabilities to provide assistance for medical adherence and mental health wellbeing.
  • March 2025: A group of researchers from Imperial College London and the University of Birmingham announced the launch of a new 4D medical device manufacturing project.
  • May 2024: Siemens Healthineers announced the opening of a new facility in North Oxfordshire intended to manufacture superconducting magnets, which are used for MRI scans. The company invested around USD 314 million in this venture. 

REPORT COVERAGE

The report provides a detailed analysis of the market and focuses on key aspects such as prominent companies, product types, and leading end users of the product. Besides this, it offers insights into the medical devices market trends and highlights key industry developments and market share analysis for key companies. In addition, the report encompasses several factors that have contributed to the growth of the market over recent years.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Growth Rate

CAGR of 5.6% from 2025-2032

Historical Period

2019-2023

Unit

Value (USD Billion)

Segmentation

By Type

·         Orthopedic Devices

·         Cardiovascular Devices

·         Diagnostic Imaging

·         IVD

·         MIS

·         Wound Management

·         Diabetes Care

·         Ophthalmic

·         Dental

·         Nephrology

·         General Surgery

·         Others

By End-User

·         Hospitals & ASCs

·         Clinics

·         Others



Frequently Asked Questions

Fortune Business Insights says that the market stood at USD 18.17 billion in 2024 and is projected to reach USD 27.90 billion by 2032.

The market is expected to exhibit steady growth at a CAGR of 5.6% during the forecast period.

The dental segment is estimated to witness the fastest growth on the basis of type.

The growing incidence of chronic and infectious diseases and the growing inclination toward a decentralized healthcare system are expected to drive the market growth.

Abbott, F. Hoffman-La Roche AG, and Danaher Corporation are some of the top players in the market.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2019-2032
  • 2024
  • 2019-2023
  • 125
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann